Buprenorphine Sublingual Tablets — Class III drug recall D-0840-2026
Ongoing recall by American Health Packaging, reported 2026-09-09, distributed nationwide. Labeling: Label Mix-up
| Recall number | D-0840-2026 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Health Packaging, Columbus, OH, United States |
| Recall initiated | 2026-08-19 |
| Classified | 2026-09-14 |
| Reported by FDA | 2026-09-09 |
| Distributed | Nationwide (US) |
| Quantity | 10,953 cartons |
| Reason classes | labeling |
| NDC | 60687-0481, 60687-0481-11, 60687-0481-21, 60687-0492, 60687-0492-11, 60687-0492-21 |
| Lot numbers | 1030023 |
| Expiration dates | 2027-06-30 |
Product
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Reason for recall
Labeling: Label Mix-up
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0840-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.